#ribavirin

Direct-acting antivirals lower the risk of cardiovascular disease to a greater extent than interferon-based regimens.

Hepatitis C knocked pro wrestler Devon “Hannibal” Nicholson out of the ring, but a cure landed him back in the fight.

This Ukrainian woman didn’t let outdated hepatitis C treatment or limited access to them, prevent her from getting necessary medical care.

Those for whom Mavyret did not work the first time had a high cure rate with this intensified retreatment regimen.

In a recent trial, 12 weeks of the drug combination worked well regardless of whether individuals had drug-resistant virus.

This hep story teller and her husband describe their hepatitis C treatments using peginterferon and ribavirin as a wild ride.

Human rights activist Philip Baldwin writes about his experiences living with hepatitis C and HIV, and his treatment for hep C.

The FDA has expanded approval of the direct-acting antiviral treatments Sovaldi and Harvoni for adolescents ages 12 and older.

A look at hepatitis C treatment side effects using the newest medicines.

Will your hepatitis C treatment work if your doctor reduces your ribavirin dose?

An analysis of forty-two clinical trials of all the approved direct acting antiviral HCV regimens.

Hepatitis C advocate Peter McLoyd transformed his bad times into good ones.

A look at the latest hepatitis C treatment for children and teens.

The antiviral drug, which for some people can be a beneficial adjunct to the new crop of hep C medications, has gotten a bad rap.

As a hepatitis C navigator, Glenna McCarthy highlights the importance of self-care.